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Abstract
Advantages of transcanalicular laser-assisted dacryocystorhinostomy (TCDCR) over conventional 
external and endonasal dacryocystorhinostomy (DCR) have been purported to include decreased 
operating time, reduced morbidity, enhanced cosmesis, avoidance of general anesthesia, and a 
shorter recovery time. However, one case of skin necrosis has recently been reported to have 
occurred following diode laser-assisted TCDCR, and we now report three additional cases that 
were evaluated by the Ophthalmic Plastic Surgery services at the University of North Carolina and 
the University of California, San Francisco. Three patients developed full-thickness tissue necrosis 
over the medial canthus following TCDCR, and two of these patients experienced persistent tissue 
breakdown at the site following reconstructive repair.
In 1990, Massaro, et al. reported the first use of a laser in dacryocystorhinostomy (DCR).1 
Over the following decades, a multitude of new laser-assisted DCR techniques were 
reported, including the direct delivery of laser energy to the wall of the lacrimal sac via 
passage of a fiberoptic probe through a canaliculus.2,3,4 This technique has been termed 
transcanalicular laser-assisted DCR (TCDCR), and its purported advantages over 
conventional external and endonasal DCR include decreased operating time, reduced 
morbidity, enhanced cosmesis, avoidance of general anesthesia, and a shorter recovery time. 
While the success rate of TCDCR has consistently been demonstrated to be lower than 
external or endonasal DCR, the procedure has generally been considered safe.5,6,7,8 
However, in 2010, Yeniad et al. published the first case of tissue necrosis following 
TCDCR.9 We herein report three additional cases of full-thickness tissue necrosis following 
TCDCR. One case was evaluated by the Ophthalmic Plastic Surgery service at the 
University of North Carolina (UNC) in 2010, and the other two were referred from a single 
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outside practice to the Ophthalmic Plastic Surgery service at the University of California, 
San Francisco (UCSF) during a two month period in early 2011.
 Case #1
A 63 year old Caucasian female was evaluated by the Ophthalmic Plastic Surgery clinic at 
the University of North Carolina in March, 2010 for a complaint of 6 months of constant 
epiphora in the right eye. She had no history of dacryocystisis, sinusitis, facial trauma, or 
eyelid, nasal, or sinus surgery. Evaluation confirmed a diagnosis of involutional NLDO, and 
TCDCR was performed in the right eye in April, 2010. A 980 nm diode laser (ITI, LCC; 
Middleton, CT) was used in single pulse mode with 10 W/pulse and a pulse duration of 9.5 
ms. Per the operative report, 1393 J of laser energy were delivered to create a full-thickness 
ostium of the lacrimal sac, lacrimal bone, and nasal mucosa. An anterior middle 
turbinectomy was performed, and a Merocel nasal pack (Medtronic, Inc.; Minneapolis, MN) 
and bicanalicular Crawford silicone tube were placed. No complications were noted. By 6 
days post-operation, the patient had developed mild pain and tenderness over the right 
lacrimal sac, and medial canthal erythema was noted. The nasal pack was removed, the nasal 
exam was felt to be within normal limits for the post-operative period, and the patient was 
started on Vigamox ophthalmic solution (Alcon, Inc.; Fort Worth, TX) and Keflex (Eli Lilly 
& Co.; Indianapolis, IN). By day 10, the patient was noted to have “pale, devitalized tissue” 
at the medial canthus. Following debridement of the tissue, a small fistulous tract from the 
medial canthus skin to the lacrimal sac was observed. On post-operative day 13, the patient 
underwent surgical drainage of the medial canthal abscess with further debridement of the 
devitalized tissue and closure of the fistula. The bicanalicular stent was felt to be in proper 
position and was left in place. Tissue specimens obtained during the operation demonstrated 
necrotic tissue with inflammation. Following this procedure, the patient’s wounds healed 
uneventfully, and the stent came out spontaneously at home during postoperative week 18. 
However, following this evaluation, the patient complained of persistent epiphora in the right 
eye.
 Case #2
An 83 year old Caucasian female attended our clinic in January 2011 for evaluation of a full-
thickness skin defect in the left medial canthal region that developed following TCDCR with 
bicanalicular stenting at an outside practice. The patient had received radioactive iodine 
therapy (RAI) for metastatic thyroid carcinoma in 1986 and underwent Mohs micrographic 
excision with reconstruction for a basal cell carcinoma at the left medial canthal region in 
2007. In early 2010, she developed epiphora and blurred vision in her left eye and was 
diagnosed with involutional nasolacrimal duct obstruction (NLDO). Left-sided TCDCR was 
performed in October, 2010. An 810 nm diode laser (ITI, LLC; Middletown, CT) was used 
in single pulse mode with 12 W/pulse and a pulse duration of 9.5 ms. Per the operative 
report, 1300J of laser energy were delivered to create a full-thickness ostium of the lacrimal 
sac, lacrimal bone, and nasal mucosa. Cottonoids soaked in mitomycin C (0.3 mg/mL) were 
held in place at the ostium site for 3 minutes. A bicanalicular Crawford silicone tube was 
placed, and no complications were noted. As part of a standard post-operative regimen, the 
patient was treated with Tobradex ophthalmic suspension (Alcon, Inc.; Fort Worth, TX) and 
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Keflex (Eli Lilly & Co.; Indianapolis, IN). At 1 month, the patient had developed skin 
breakdown in the left medial canthal region which progressed to full thickness necrosis by 
two months post-TCDCR (see Figure 1A). Neosporin ointment (Pfizer, Inc.; New York, NY) 
was applied to the affected skin, and she was referred to the Ophthalmic Plastic Surgery 
service at UCSF. The silicone tubes were removed during the post-operative course by the 
outside ophthalmologist. At 3 months post-TCDCR, the patient underwent debridement of 
the defect and repair with a glabellar flap. An intra-operative incisional biopsy of the defect 
border demonstrated basal cell carcinoma; however, it was felt that the debridement of the 
surrounding tissue had likely been sufficient to remove residual basal cell carcinoma. 
Breakdown of the flap occurred at 8 weeks following her repair, and a decision was made to 
allow the wound to granulate without further intervention (see Figure 2A). At the most 
recent observation at 2 months status post repair, the wound had still not fully healed.
 Case #3
A 63 year old Caucasian female attended our clinic in March 2011 for evaluation of a full-
thickness tissue defect in the left medial canthal region that developed following TCDCR 
with bicanalicular stenting at the same outside practice. The patient had complained of 7 
years of epiphora in her left eye and was diagnosed with involutional NLDO. Left-sided 
TCDCR was performed in January, 2011. The same 810 nm diode laser (ITI, LLC; 
Middletown, CT) was used in single pulse mode with 12 W/pulse and a pulse duration of 9.5 
ms. Per the operative report, 900 J of laser energy were delivered in an attempt to create an 
ostium; however, the surgeon noted difficulty in penetrating the tissue and abandoned laser 
treatment after noting blanching of the skin at the medial canthus. Cold saline compresses 
were applied to the area, and the procedure was completed via a non-laser-assisted 
endonasal approach with placement of a bicanalicular Crawford silicone tube. The 
appearance of a “first-degree burn” was noted over the medial canthal area at post-operative 
day 1, and skin breakdown was noted at post-operative day 7. Neosporin ointment (Pfizer, 
Inc.; New York, NY) was applied to the affected skin, and she was treated with Tobradex 
ophthalmic suspension (Alcon, Inc.; Fort Worth, TX) and Keflex (Eli Lilly & Co.; 
Indianapolis, IN). By 5 weeks, she had developed full-thickness tissue necrosis in the left 
medial canthal region (see Figure 1B). The silicone tubes were removed during the 
postoperative course by the outside ophthalmologist, and the patient was referred to the 
Ophthalmic Plastic Surgery service at UCSF. The patient underwent debridement of the 
defect and repair with a glabellar flap at 10 weeks post-TCDCR. During this procedure, 
multiple bony erosions were observed in the frontal process of the maxilla, which appeared 
consistent with laser damage. There was breakdown of the flap at 6 weeks following her 
repair, and the patient elected to undergo a second repair, this time with an advancement flap 
at 7 weeks post-TCDR (see Figure 2B). By 2 weeks following the second reconstruction, the 
patient again experienced flap breakdown, and it was decided to allow the wound to 
granulate (see Figure 3). At the most recent observation at 7 months following the initial 
repair, the wound had still not fully healed.
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Previous studies of TCDCR have shown it to be a relatively safe procedure. Drnovsek-Olup 
and Beltram performed 126 successive diode laser-assisted TCDCRs and reported ipsilateral 
lower eyelid swelling and bruising as their only complications10, and in 118 consecutive 
diode laser-assisted TCDCR cases reported by Hong et al., the only complication was a 
single instance of “thermal injury to the canaliculus” which was repaired with canalicular 
suturing.5 Furthermore, a prospective series of 25 cases of diode laser-assisted TCDCR by 
Plaza et al., reported “minimal” complications including bleeding and difficulty in dilation 
and probing of the canaliculi.11 However, the occurrence of a small fistula connecting the 
canalicular system with the skin in one case, and the cauterization of the superior canaliculus 
in another, was reported from a series 29 diode laser-assisted TCDCR procedures by Eloy, et 
al in 2000.12 In 2010 Yeniad et al. reported a case of localized tissue necrosis which 
developed within 2 weeks following diode laser-assisted TCDCR.9 Repair with an 
advancement flap failed, and culture specimens taken from the nasal cavity grew 
Aspergillus. The patient was treated with oral amphotericin B, and the wound eventually 
healed by granulation. Thermal damage from the diode laser was suggested as a cause for 
the observed tissue necrosis.
Our cases represent the third, fourth, and fifth reports of tissue necrosis following TCDCR. 
The case at UNC was the first encountered by the treating physician. Similarly, prior to the 
two consecutive complicated cases evaluated at UCSF, the referring ophthalmologist 
reported 144 uncomplicated cases of TCDCR. In this series, the same company 
manufactured all three diode laser units, and the single unit used in two of the three 
procedures was sent for evaluation following the first complication. The company found no 
evidence of malfunction and returned the laser. Following the second complication, the laser 
was again sent back to the company. Damage to the diode was reported, although the 
specific malfunction was unspecified.
In each case, the power setting of the diode laser (10–12 W/pulse) was below the level of 15 
W/pulse which has been reported to cause heat lateralization and tissue charring and is 
comparable to the power settings used in other published series of diode laser-assisted 
TCDCR.10,11,12,13 However, total laser energy is not consistently reported in published 
series of TCDCR, and in the series by Drnovsek-Olup and Beltram, no significant 
complications related to thermal damage were seen with a total laser energy range of 195–
685 J (average=245 J). While Yeniad et al. do not report the laser energy used in their case 
of tissue necrosis, the total energy amounts used in the present three cases (1393 J, 900 J, 
and 1300 J) are notably higher than those in Drnovsek-Olup and Beltram. During the initial 
reconstruction procedure of patient #3, punctate erosions were observed on the frontal 
process of the maxilla, which is considerably thicker than the adjacent and immediately 
posterior lacrimal bone. It is possible that, in this patient, the suture of the frontal process 
and the lacrimal bone extended more posteriorly in the lacrimal fossa, resulting in the 
application of increased laser energy in order to create a bony opening. The high quantities 
of laser energy could have caused local tissue damage sufficient to impair the normal 
wound-healing process and lead to the eventual necrosis of the affected tissue.
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Case #2 also featured several complicating factors that could have contributed to local tissue 
breakdown. One such factor is the intra-operative use of topical mitomycin C. Mitomycin C 
is an antimetabolite that has been used in TCDCRs in an attempt to prevent closure at the 
lacrimal osteotomy site.5,8,11,14 A prospective case series by Henson, et al. was the first 
study to examine the use of adjunctive mitomycin C in diode laser-assisted TCDCR, and the 
success rate of 87.5% at 12 months was relatively higher than many other reports of TCDCR 
outcomes.5,8,12,13 Of the 40 reported cases, there were no complications attributed to the use 
of mitomycin C.
Another confounding factor is the history of RAI for the treatment of thyroid carcinoma. In 
this procedure, systemically administered radioactive iodine molecules (I131) are 
preferentially metabolized by thyroid follicular cells, leading to their destruction. The 
association between RAI and NLDO has been well established, and Morgenstern, et al. 
demonstrated the presence of sodium-iodide symporters in the epithelium of the lacrimal 
sac.15,16,17,18 It is possible that the local concentration of radioactivity contributed to 
damage of the surrounding tissue in this case.
Finally, the patient reported a history of basal cell carcinoma at the left medial canthus. She 
had previously undergone resection of the lesion and was presumed to be cancer-free at the 
time of her TCDCR. Following the development of local skin necrosis, a biopsy of the 
wound margin was taken in our clinic and showed no evidence of malignancy. Another 
biopsy of the wound margin taken intra-operatively was positive for superficial basal cell 
carcinoma, which raises the possibility that recurrent or residual malignancy (or the previous 
surgical manipulation of the canthal area) could have contributed to the eventual tissue 
breakdown. Given the extensive removal of tissue during the repair, it was felt that any 
residual carcinoma was likely to have been excised, and the patient elected to pursue a 
course of watchful waiting.
The case reported by Yeniad, et al. was similarly complicated by a culture taken from the 
nasal cavity after the onset of necrosis that grew Aspergillus. However, it was unclear if the 
mold contributed to the development of tissue necrosis or if it was an opportunistic infection 
that established itself following breakdown of the skin barrier. The presence of confounders 
in these cases suggests that underlying factors may compromise the tissue and predispose 
patients to the development of skin necrosis following the application of laser energy, 
particularly in high amounts. However, an excessive amount of laser energy alone may be 
enough to cause necrosis, as evidenced by the absence of identified risk factors in cases #1 
and #3.
Another striking feature of these cases is the failure of two of the three reconstructions. 
Despite two separate attempts at repair in case #3, there was recurrent flap breakdown, and 
the wound had not yet closed completely when last observed 7 months post-operatively. This 
implies a profound and lasting damage to local tissues, which is significant enough to impair 
the viability of healthy tissue transferred into the wound bed; notably, even tissue possessing 
a pedicle-based blood supply. The repair in case #2 was performed at 3 months post-
TCDCR, and the first repair in case #3 was performed at 10 weeks post-TCDCR followed 
by a second attempt 7 weeks later. The exact timing of the repair in Yeniad, et al. is not 
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reported. The timing of the repair in both of these cases was influenced by the patients’ 
expressed desires for improved cosmesis, and it is possible that further delays in the 
reconstruction attempts may have allowed the tissues to recover and increased the likelihood 
of success.
Lastly, skin necrosis may not be a complication unique to TCDCR. In 1998, Salour and 
Montazerin reported two cases of incision site skin necrosis following external DCR. 19 
However, one of these patients was found to have a post-operative blood glucose level of 
355 mg/100 dl, and the other’s surgeon reported the occurrence of “excessive cauterization” 
during the procedure. These factors were hypothesized to have contributed to poor wound 
healing, and, in contrast to the current cases, the one patient who pursued reconstructive 
surgery was successfully repaired with an advancement flap.
In conclusion, full thickness local tissue necrosis is a likely rare, but potential complication 
following diode laser-assisted TCDCR. Patients with certain underlying factors may be at 
greater risk; however, the presence of these factors does not appear necessary for the 
development of tissue necrosis. Additional research is necessary to determine the nature of 
the underlying tissue damage. Furthermore, once necrosis occurs, it may be refractory to 
subsequent reconstruction. These findings should be considered when comparing the risks 
and benefits of TCDCR versus other DCR procedures.
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(A) Patient #2; full-thickness skin necrosis over the left medial canthus. (B) Patient #3; full-
thickness skin necrosis over the left medial canthus.
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(A) Patient #2; recurrence of skin necrosis following reconstruction. (B) Patient #3; 
recurrence of skin necrosis following the first reconstruction attempt.
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Patient #2; recurrence of skin necrosis following the second reconstruction attempt.
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